Dyne Therapeutics, Inc. DYN Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Dyne Therapeutics, Inc.’s reported figures.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s free cash flow?
- Dyne Therapeutics, Inc. (DYN) reported free cash flow of -$145.14M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s free cash flow changed year-over-year?
- Dyne Therapeutics, Inc.'s free cash flow decreased by 35.8% year-over-year, from -$106.87M to -$145.14M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s free cash flow?
- Over 4 years (2021 to 2025), Dyne Therapeutics, Inc.'s free cash flow has grown at a 34.7% compound annual growth rate (CAGR), from -$123.18M to -$405.13M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.